End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
114,700 KRW | +3.71% | +2.59% | -8.61% |
05-20 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
05-16 | GC Biopharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |